unknown
Stage
About
Calico Biosystems is a Lausanne-based company that provides a preclinical oncology drug development platform using New Approach Methodologies (NAM) to test drug efficacy directly on intact, cryopreserved patient tumors. Their proprietary stack combines global tumor sourcing, cryopreservation, and AI-driven efficacy scoring to deliver predictive efficacy data, indication prioritization, and experimental biomarkers for pharma and biotech clients.
Explore Calico Biosystems's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.